View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
  2. Company News
November 9, 2018updated 08 Nov 2018 4:01pm

Deals this week: Philips, HeartHero, SirenMD

Royal Philips has partnered with Allm to develop novel mobile diagnostic, acute and homecare products. 

Royal Philips has partnered with Allm to develop novel mobile diagnostic, acute and homecare products.

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

Philips has acquired a minority interest in Allm as part of the deal.

Allm’s mobile communications solutions will be integrated with Philips’ emergency care and resuscitation solutions.

The partnership will enhance the digitisation of Philips’ emergency care product portfolio with Allm’s next-generation technologies and medical communications platforms. It will enable the two companies to improve the health management of patients.

Based in the Netherlands, Royal Philips is a technology company specialising in the areas of healthcare and lighting, while Allm is a medical communications platform company in Japan.

HeartHero has entered an agreement to license VivaQuant MDSP’s cardiac arrhythmia detection technology.

HeartHero will employ the technology for the advancement of its portable Automated External Defibrillator (AED), which is used for the detection of life-threatening heart disorders.

"The integration of technologies will also reduce the gap between the patient and emergency medical services to improve the chances of survival in the patients."

VivaQuantMDSP’s technology will help improve the processing and analysis of ECG data by its state-of-the-art embedded algorithms of its ECG software.

The integration of technologies will also reduce the gap between the patient and emergency medical services (EMS) to improve the chances of survival in the patients.

HeartHero is a medical device start-up, while VivaQuant MDSP is a medical device company. Both companies are based in the US.

DJO has signed a deal to become the exclusive sales representative for the SirenMD’s sports team market.

SirenMD software compiles injury data of athletes and provides a comprehensive report to the conference and member institutions. It offers a more integrated, compliant and efficient sharing of patients’ data.

DJO will provide a new and innovative care platform to existing customers and sales channels. It will enable SirenMD to provide improved care for athletes and sports teams.

DJO is a medical device company, while SirenMD is a technology platform company focussing on athlete health. The parties are based in the US.

Related Companies

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network